The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smokingon Parkinson's disease

Citation
P. Costa-mallen et al., The EcoRV genetic polymorphism of human monoamine oxidase type A is not associated with Parkinson's disease and does not modify the effect of smokingon Parkinson's disease, NEUROSCI L, 278(1-2), 2000, pp. 33-36
Citations number
19
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
278
Issue
1-2
Year of publication
2000
Pages
33 - 36
Database
ISI
SICI code
0304-3940(20000107)278:1-2<33:TEGPOH>2.0.ZU;2-N
Abstract
We previously observed an association with Parkinson's (PD), and modificati on of the effect of smoking on PD, by a polymorphism of the monoamine oxida se B (MAO-B) gene. The A form of monoamine oxidase (MAO-A) shares with MAO- B many characteristics that could be relevant to PD, especially proneuroxic ant bioactivation and dopamine metabolism. MAO-A is also inhibited by tobac co smoke, which bears an apparent protective effect on PD. We investigated the possibility that MAO-A genetic variants may also be involved in predisp osition to PD and in modification of the effect of smoking. Three-hundred a nd seventy-one subjects - 145 idiopathic PD cases and 226 age/gender-matche d controls - were genotyped for the EcoRV polymorphism of MAO-A gene which has been related to increased enzyme activity. MAO-A EcoRV polymorphism was neither significantly associated with PD nor did it modify the inverse rel ationship with smoking. These results suggest that the EcoRV polymorphism o f MAO-A is not an important biomarker of PD risk. Published by Elsevier Sci ence Ireland Ltd.